Barely Significant
← all excerpts

Characterization of binding, functional activity, and contractile responses of the selective 5-HT<sub>1F</sub> receptor agonist lasmiditan.

Br J Pharmacol · 2019 · PMC6965684 · PMID 31418454

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Lasmiditan only showed a trend to decrease blood pressure at the highest (supratherapeutic dose), which, based on the affinity of lasmiditan (see Table 1 ), could be due to a non‐selective activation of prejunctional 5‐HT 1D receptors and subsequent inhibition of sympathetic perivascular nerves (Villalón et al., 1998 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.